A consensus statement on the gender perspective in lung cancer


Por: Isla, D, Majem, M, Vinolas, N, Artal, A, Blasco, A, Felip, E, Garrido, P, Remon, J, Baquedano, M, Borras, JM, Trill, MD, Garcia-Campelo, R, Juan, O, Leon, C, Lianes, P, Lopez-Rios, F, Molins, L, Planchuelo, MA, Cobo, M, Paz-Ares, L, Trigo, JM, de Castro, J

Publicada: 1 may 2017
Resumen:
Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who are diagnosed at an increasingly younger age compared with men. One of the main reasons for this rise is women taking up smoking. However, many non-smoking women also develop this disease. Other risk factors implicated in the differential development of lung cancer in women are genetic predisposition, tumour histology and molecular profile. Proportionally more women than men with lung cancer have a mutation in the EGFR gene. This consensus statement reviews the available evidence about the epidemiological, biological, diagnostic, therapeutic, social and psychological aspects of lung cancer in women.

Filiaciones:
Isla, D:
 Lozano Blesa Clin Univ Hosp, Dept Med Oncol, Avda San Juan Bosco 15, Zaragoza 50009, Spain

Majem, M:
 St Pau Univ Hosp, Dept Med Oncol, Barcelona, Spain

Vinolas, N:
 Clin Hosp, Dept Med Oncol, Barcelona, Spain

Artal, A:
 Miguel Servet Univ Hosp, Dept Med Oncol, Zaragoza, Spain

Blasco, A:
 Valencia Gen Univ Hosp, Dept Med Oncol, Valencia, Spain

Felip, E:
 Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

Garrido, P:
 Ramon & Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain

Remon, J:
 Mataro Univ Hosp, Dept Med Oncol, Barcelona, Spain

Baquedano, M:
 Lozano Blesa Clin Univ Hosp, Dept Med Oncol, Avda San Juan Bosco 15, Zaragoza 50009, Spain

Borras, JM:
 Univ Barcelona, Spanish Natl Hlth Syst, Canc Strategy, Barcelona, Spain

Trill, MD:
 Atrium, Psycooncol & Clin Psychol, Madrid, Spain

Garcia-Campelo, R:
 A Coruna Univ Hosp, Dept Med Oncol, La Coruna, Spain

Juan, O:
 La Fe Univ Hosp, Dept Med Oncol, Valencia, Spain

Leon, C:
 Terrassa Hosp, Psycooncol Unit, Sabadell, Spain

 Parc Tauli Univ Hosp, Sabadell, Spain

Lianes, P:
 Mataro Univ Hosp, Dept Med Oncol, Barcelona, Spain

Lopez-Rios, F:
 HM Sanchinarro Univ Hosp, Dept Pathol, Targeted Therapies Lab, Madrid, Spain

Molins, L:
 Clin Hosp, Dept Thorac Surg, Barcelona, Spain

Planchuelo, MA:
 Consejeria Sanidad, Humanizat Healthcare Dept, Madrid, Spain

Cobo, M:
 Virgen Victoria Univ Hosp, Dept Med Oncol, Malaga, Spain

Paz-Ares, L:
 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain

Trigo, JM:
 Virgen Victoria Univ Hosp, Dept Med Oncol, Malaga, Spain

de Castro, J:
 La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
ISSN: 1699048X
Editorial
SPRINGER INTERNATIONAL PUBLISHING AG, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, España
Tipo de documento: Review
Volumen: 19 Número: 5
Páginas: 527-535
WOS Id: 000399229600001
ID de PubMed: 27885542
imagen Green Accepted

MÉTRICAS